Answer
Quizartinib is primarily metabolised in vitro by CYP3A4 and CYP3A5 through oxidative pathways to active metabolite AC886, which is further metabolised by the same enzymes.
Sources for this answer
- Vanflyta 17.7 mg film-coated tabletDaiichi Sankyo UK Limited · emc · SmPC §5.2 Pharmacokinetic properties · Version 4Document updated
Sources checked